AstraZeneca (AZ) has shared positive results from a phase 3b study of its anti-inflammatory reliever rescue therapy Airsupra ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

Medscape Education is proud to announce the presentation of eight innovative educational research publications at the ...

In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...

VML France has announced the appointment of Philippe Huot-Louradour as director of VML Health France. Hout, who has also been ...

Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...

MSD – known as Merck & Co in the US and Canada – has received approval from the Medicines and Healthcare products Regulatory ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical education ...

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores ...

Sanofi has unveiled plans to invest “at least” $20bn into the US by 2030, with the commitment including a significant ...

Johnson & Johnson (J&J) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its ...